← Open Payments lookup

MARIE THOMPSON: Open Payments

NPI 1609298280 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,303 in 63 payments from 13 companies in 2025. Trend: 2023 $1,523 · 2024 $1,866 · 2025 $1,303

Food & beverage: $1,303
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.12$296
Neurocrine BioSciences, Inc.12$224
ABBVIE INC.8$163
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$153
E.R. Squibb & Sons, L.L.C.6$116
Lundbeck LLC4$94
Takeda Pharmaceuticals U.S.A., Inc.2$60
Alkermes, Inc.2$53
Axsome Therapeutics, Inc.3$53
Supernus Pharmaceuticals, Inc.2$33

Products named: REXULTI, INGREZZA, VRAYLAR, CAPLYTA, COBENFY, TRINTELLIX, ARISTADA, Auvelity.

Industry payments across NY — which companies pay providers there.